Japan· JP-3999066F1020
ケノデオキシコール酸
A chenodeoxycholic acid product containing ケノデオキシコール酸, registered in Japan by 藤本製薬, on the national reimbursement list. The same ATC class is registered in 12 of our 19 countries.
Checked against MHLW / PMDA (Japan) on
Informational only — not a medical device.
Where it is registered
Chenodeoxycholic acid is registered in 12 of 19 countries.
Countries holding a registration under ATC A05AA01 (chenodeoxycholic acid), each read from that country’s own register.
- This record: Japan, from MHLW / PMDA (Japan)
- 7 of them publish a price we can compare per daily dose
Chenodeoxycholic acid · ATC A05AA01
12 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
The record
At a glance
MHLW / PMDA (Japan)- Active substance
- ケノデオキシコール酸
- Manufacturer
- 藤本製薬
- Country
- Japan (JP)
- ATC code
- A05AA01
- ATC class
- Chenodeoxycholic acid
- Defined daily dose
- 1 g, O
- Reimbursed
- Yes
- Source register
- MHLW / PMDA (Japan)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
57 interactions on record for chenodeoxycholic acid.
Graded by severity as the source publishes them — 7 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Chenodeoxycholic acid · interactions on record
57 records
- 7 severe
- 50 moderate
Most severe, free to view
- MipomersenC10AX11severe
- LomitapideC10AX12severe
- PexidartinibL01EX15severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under A05AA01
Chenodeoxycholic acid, as other registers publish it.
- SwitzerlandAcido chenodesossicolico Leadiant 250 mg, capsula rigidaCD PHARMA (SUISSE) SA
- United KingdomChenodeoxycholic acid 200mg tabletsSpecial Order
- United KingdomChenodeoxycholic acid 250mg capsulesLeadiant Biosciences Ltd
- United KingdomChenodeoxycholic acid 250mg capsulesSpecial Order
- PolandChenodeoxycholic acid LeadiantLeadiant GmbH
- DenmarkChenodeoxycholic acid LeadiantLeadiant Biosciences Ireland Limited
- NorwayChenodeoxycholic acid LeadiantLeadiant Biosciences Ireland Limited
- IcelandChenodeoxycholic acid LeadiantLeadiant GmbH
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of MHLW / PMDA (Japan). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b5e67a4d-ad16-4f21-bfa9-fcc2b82b08f2 GET /v1/drugs/b5e67a4d-ad16-4f21-bfa9-fcc2b82b08f2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"spec": "１２５ｍｇ１包",
"marks": null,
"source": "mhlw",
"remarks": null,
"yj_code": "3999066F1020",
"category": "内用薬",
"price_yen": 22043,
"generic_name": "ケノデオキシコール酸",
"product_name_jp": null,
"therapeutic_class": "3999",
"transitional_expiry": null
}See everything about chenodeoxycholic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.